Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and Serious Illness through Cedar Clinical Research Post published:October 3, 2023 Post category:Press Release
Numinus Wellness Inc. Announces At-The-Market Offering Equity Program Post published:September 26, 2023 Post category:Press Release
Numinus Congratulates MAPS on its Phase 3 Study Results Published in Nature Medicine Post published:September 19, 2023 Post category:Press Release
Numinus Takes Actions to Accelerate its Path to Profitability by Focusing on Positive Cash Flow Generating Operations Post published:September 19, 2023 Post category:Press Release
Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, August 17, 2023 USA – English USA – Polski USA – slovenčina USA – Français USA – Deutsch Post published:August 9, 2023 Post category:Press Release
Numinus Wellness Inc. Reports Q3 2023 Results Post published:July 17, 2023 Post category:Press Release
Numinus to Present at the Small Cap Growth Virtual Investor Conference on July 13, 2023 Post published:July 11, 2023 Post category:Press Release
Numinus to Host Q3 2023 Results Conference Call on July 17, 2023 Post published:June 29, 2023 Post category:Press Release
Numinus Announces Agreement with HealingMaps to Drive Strategic Clinic Growth Post published:June 22, 2023 Post category:Press Release
Numinus Announces Partnership with MAPS to Support Therapist Psychedelic Experiential Training Post published:June 15, 2023 Post category:Press Release